FDA recall, , Moderate risk
New York Blood Center Fresh Frozen Plasma and Red Blood Cells
The products were collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen on more than one occasion.
Recall ended Jun 24, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
New York Blood Center Inc began a recall on August 29, 2025, for Red Blood Cells, Leukocytes Reduced and Fresh Frozen Plasma. The products were collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen (anti-HBc) on more than one occasion and were distributed in Minnesota. The FDA added the recall to its Enforcement Report on June 24, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
2 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen (anti-HBc) on more than one occasion, were distributed.
Fresh Frozen Plasma
Reason: Fresh Frozen Plasma, collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen (anti-HBc) on more than one occasion, were distributed.
Recall details
- Company began the recall
- Sold in
- Company
- New York Blood Center Inc
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99052
- Recall numbers
- B-0096-2026 to B-0097-2026
All recalls from New York Blood Center Inc
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
